Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Celgene Corp., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014
Short-term borrowings and current portion of long-term debt	1,498)	—)	500)	501)	502)	1,497)	—)	—)	1,400)	500)	500)	501)	501)	—)	—)	—)	1,200)	1,363)	504)	606)	100)	192)	870)
Accounts payable	421)	327)	340)	418)	292)	294)	320)	305)	263)	272)	240)	247)	235)	230)	220)	241)	189)	205)	204)	198)	197)	185)	149)
Accrued expenses and other current liabilities	2,964)	3,035)	2,975)	2,987)	2,705)	2,615)	2,672)	2,523)	2,265)	2,379)	1,808)	2,115)	1,847)	1,696)	1,542)	1,648)	1,674)	1,323)	1,347)	1,267)	1,053)	1,066)	1,358)
Income taxes payable	82)	280)	72)	78)	105)	32)	54)	84)	55)	32)	25)	41)	4)	13)	15)	20)	6)	11)	13)	13)	15)	16)	17)
Current portion of deferred revenue	44)	43)	68)	73)	79)	64)	69)	75)	66)	57)	56)	55)	62)	49)	58)	61)	75)	58)	29)	29)	34)	34)	31)
Current liabilities	5,009)	3,685)	3,955)	4,057)	3,683)	4,502)	3,115)	2,987)	4,049)	3,240)	2,629)	2,959)	2,649)	1,987)	1,834)	1,969)	3,144)	2,960)	2,097)	2,112)	1,398)	1,492)	2,425)
Deferred revenue, net of current portion	16)	40)	76)	73)	74)	63)	35)	34)	46)	31)	29)	28)	28)	28)	29)	30)	29)	30)	27)	28)	28)	28)	25)
Income taxes payable	2,454)	2,256)	2,232)	2,190)	2,451)	2,368)	2,514)	2,490)	469)	463)	441)	420)	370)	346)	327)	324)	323)	307)	288)	273)	264)	259)	245)
Deferred income tax liabilities	2,854)	2,676)	2,714)	2,753)	2,811)	2,771)	2,777)	1,327)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Other non-current tax liabilities	—)	—)	—)	—)	—)	—)	—)	—)	2,519)	2,519)	2,519)	2,519)	2,519)	2,519)	2,519)	2,519)	—)	—)	—)	—)	—)	—)	—)
Other non-current liabilities	654)	685)	716)	477)	594)	556)	672)	544)	1,929)	1,825)	1,774)	1,771)	1,734)	1,821)	1,912)	2,042)	4,200)	1,872)	2,000)	2,137)	2,208)	2,229)	1,300)
Long-term debt, net of discount, excluding current portion	18,289)	19,790)	19,781)	19,769)	19,742)	19,754)	20,271)	15,838)	12,874)	13,783)	13,784)	13,789)	13,803)	14,312)	14,268)	14,250)	14,298)	6,256)	6,303)	6,266)	6,737)	6,743)	4,224)
Non-current liabilities	24,267)	25,447)	25,519)	25,262)	25,672)	25,512)	26,269)	20,233)	17,837)	18,621)	18,547)	18,527)	18,454)	19,026)	19,055)	19,166)	18,850)	8,464)	8,618)	8,703)	9,237)	9,259)	5,795)
Total liabilities	29,276)	29,132)	29,474)	29,319)	29,355)	30,014)	29,384)	23,220)	21,886)	21,861)	21,176)	21,486)	21,103)	21,013)	20,889)	21,134)	21,994)	11,424)	10,716)	10,815)	10,635)	10,751)	8,220)
Preferred stock, $.01 par value per share; none outstanding	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Common stock, $.01 par value per share	10)	10)	10)	10)	10)	10)	10)	10)	10)	10)	10)	10)	10)	10)	9)	9)	9)	9)	9)	9)	9)	9)	5)
Common stock in treasury, at cost	(26,334)	(26,331)	(26,298)	(26,336)	(26,315)	(25,700)	(22,946)	(20,243)	(17,243)	(17,069)	(16,557)	(16,281)	(16,130)	(15,851)	(15,432)	(14,052)	(13,613)	(12,789)	(11,804)	(10,699)	(10,092)	(9,837)	(9,319)
Additional paid-in capital	16,072)	15,753)	15,381)	14,978)	14,756)	13,835)	14,077)	13,806)	13,604)	13,174)	12,749)	12,378)	11,981)	11,666)	11,370)	11,119)	10,827)	10,496)	10,186)	9,827)	9,440)	9,166)	8,907)
Retained earnings	22,366)	20,675)	19,104)	17,559)	16,486)	15,404)	14,359)	13,061)	13,142)	12,093)	11,032)	10,074)	9,645)	9,473)	8,875)	8,074)	7,513)	7,548)	7,191)	6,472)	5,859)	5,350)	4,752)
Accumulated other comprehensive income (loss)	(27)	(56)	(32)	(50)	(77)	(119)	(328)	287)	337)	237)	410)	419)	145)	251)	252)	768)	639)	1,058)	1,182)	915)	553)	164)	140)
Stockholders’ equity	12,087)	10,051)	8,165)	6,161)	4,860)	3,430)	5,172)	6,921)	9,850)	8,445)	7,644)	6,599)	5,650)	5,549)	5,075)	5,919)	5,376)	6,322)	6,765)	6,525)	5,768)	4,851)	4,485)
Total liabilities and stockholders’ equity	41,363)	39,183)	37,639)	35,480)	34,215)	33,444)	34,556)	30,141)	31,736)	30,306)	28,820)	28,086)	26,754)	26,562)	25,964)	27,053)	27,369)	17,746)	17,481)	17,340)	16,403)	15,602)	12,705)

Short-term borrowings and current portion of long-term debt: This item exhibited fluctuations across the periods, with values starting at 870 million in Mar 2014, dropping to as low as 100 million in Sep 2014, then surging to 1,363 million in Jun 2015 and peaking again near 1,498 million in late 2019. Overall, the borrowing shows volatility with a tendency to increase towards the end of the period analyzed.
Accounts payable: Accounts payable demonstrated a gradual increasing trend over the period, rising from 149 million in Mar 2014 to peaks exceeding 400 million by late 2018 and 2019. Although some fluctuations occurred, the general direction points to an increase in obligations to suppliers or creditors.
Accrued expenses and other current liabilities: This amount steadily increased from approximately 1,358 million in Mar 2014 to nearly 3,000 million by late 2019, indicating growing short-term liabilities related to operational costs and other accruals. The upward trend suggests intensifying operational or contingent costs over time.
Income taxes payable (current): Current income taxes payable exhibited considerable variability, fluctuating between single digits and highs around 280 million in Sep 2019. This inconsistency suggests varying tax obligations influenced by changing profitability or tax strategies.
Current portion of deferred revenue: The current portion of deferred revenue remained relatively stable, generally fluctuating between 30 and 80 million with minor periodic increases and decreases, indicating consistent recognition of deferred income within one year.
Current liabilities: Current liabilities displayed an overall upward trajectory, beginning near 2,425 million in early 2014, dipping in some quarters, and reaching over 5,000 million by late 2019. This increase primarily reflects rising accrued expenses and accounts payable.
Deferred revenue, net of current portion: This non-current deferred revenue was stable at lower values early on, increasing gradually after 2016 from around 30 million to over 70 million, indicating growing amounts of revenue deferred beyond one year.
Income taxes payable (non-current): Non-current income taxes payable showed a rising trend, from approximately 245 million in early 2014 to peaks exceeding 2,500 million in 2017 and thereafter maintaining elevated levels above 2,000 million, reflective of long-term tax liabilities or deferred tax obligations.
Deferred income tax liabilities: Data for deferred income tax liabilities is available only starting 2017, showing significant increases from 1,327 million in Mar 2017 to over 2,800 million by late 2019, indicating accumulated deferred tax obligations.
Other non-current tax liabilities: Reported at 2,519 million consistently from 2015 through 2019, suggesting a stable long-term tax liability commitment during this period.
Other non-current liabilities: Other non-current liabilities varied widely, starting near 1,300 million in 2014, spiking to over 4,200 million in mid-2015, then fluctuating and eventually decreasing slightly toward the end of the period to around 650 million, indicating significant but unstable non-current obligations.
Long-term debt, net of discount: Long-term debt increased remarkably from approximately 4,200 million in early 2014 to a peak above 20,000 million in 2017 and 2018, followed by a slight decrease near 18,000 million near the end of 2019. This represents a substantial rise in long-term financing.
Non-current liabilities: Non-current liabilities followed a similar pattern to long-term debt, rising from about 5,800 million in 2014 to nearly 26,000 million at peak in 2017-2018 before marginally declining in 2019, reflecting increased long-term obligations.
Total liabilities: Total liabilities more than tripled, increasing from approximately 8,200 million in early 2014 to around 29,000 million by 2019, consistent with expansions in both current and non-current liabilities.
Common stock and treasury stock: Common stock par value remained stable at around 9-10 million throughout the periods, indicating no significant new issuance or buybacks reflected in par value. Treasury stock, however, consistently increased in a negative balance from about -9,300 million in early 2014 to around -26,300 million by 2019, suggesting persistent repurchases or holdings of treasury shares.
Additional paid-in capital: This equity component steadily increased from 8,907 million in 2014 to over 16,000 million by 2019, reflecting continued capital contributions or issuance above par value.
Retained earnings: Retained earnings showed solid growth, more than quadrupling from around 4,752 million in early 2014 to over 22,000 million by late 2019, indicative of accumulated profits and reinvested earnings.
Accumulated other comprehensive income (loss): Accumulated other comprehensive income/loss showed fluctuations, starting positive near 140 million in 2014, increasing substantially upwards to over 1,100 million in 2015, but then declining and turning negative by 2018 and 2019, reaching lows around -56 million. This variability suggests changes in unrealized gains/losses, foreign currency adjustments, or other comprehensive income components.
Stockholders’ equity: Stockholders’ equity fluctuated with a general upward trend from about 4,485 million in early 2014 to over 12,000 million at the end of the period in 2019. The equity saw some temporary declines, possibly due to increases in treasury stock or losses in comprehensive income, but overall increased mainly due to rising retained earnings and additional paid-in capital.
Total liabilities and stockholders’ equity: The combined total grew from approximately 12,700 million in 2014 to over 41,000 million by 2019, reflecting growth in the company’s balance sheet size driven by rising liabilities and equity.

Download chart

Celgene Corp. (NASDAQ:CELG)

Balance Sheet: Liabilities and Stockholders’ Equity Quarterly Data

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data